| Erythropoeitin Stimulating Agents Take a Hit as New Reimbursement Structure is ... - MarketWatch (press release) |
|
|
MarketWatch (press release) While the impact of these two most recent events is not yet known, the new reimbursement program for drugs administered during dialysis treatments ("Dialysis Bundle"), which went into effect in January of this year, is clearly having a negative impact |